Cellid, Co., Ltd.

KOSDAQ:A299660 Voorraadrapport

Marktkapitalisatie: ₩95.6b

Cellid Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Yuil Kang Chang

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Is Cellid (KOSDAQ:299660) Using Debt In A Risky Way?

Feb 28
Is Cellid (KOSDAQ:299660) Using Debt In A Risky Way?

Is Cellid (KOSDAQ:299660) In A Good Position To Invest In Growth?

Mar 04
Is Cellid (KOSDAQ:299660) In A Good Position To Invest In Growth?

Cellid (KOSDAQ:299660) Is In A Good Position To Deliver On Growth Plans

Nov 19
Cellid (KOSDAQ:299660) Is In A Good Position To Deliver On Growth Plans

CEO

Yuil Kang Chang

no data

Tenure

Chang Yuil Kang is Chief Executive Officer and Representative Director, Cellid Co., Ltd. Chang Yuil Kang is Honorary Professor at College of Pharmacy, Seoul National University; President of Cell-Based Imm...